Clinical trial Recruiting at 1 site Interventional Ages 7 to 17

Screening for sensory deficits in childhood cancer survivors

Official title: Highlighting Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Run by Washington University School of Medicine · NCT05582551 · Data updated 2026-11-12

This study is trying to find a better way to check for sensory problems in childhood cancer survivors by using their treatment history to identify who needs testing.

More Childhood Cancer trials

Quick facts

Study typeInterventional
Ages7 Years to 17 Years
SexAll
Enrollment146 (estimated)
SponsorWashington University School of Medicine
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedAugust 2, 2023
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedJune 15, 2026
Trial IDNCT05582551 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are childhood cancer survivors aged 7 to 17 who completed their cancer treatment 6 months to 2 years prior and are followed at the Washington University School of Medicine.

Probably not a fit

Patients currently undergoing active cancer treatment or those already receiving care for sensory deficits may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to improve the screening process for sensory deficits in childhood cancer survivors by identifying patients at risk based on their treatment history. Collaborators at Washington University School of Medicine will create a document called HPARSS that links therapy-related risks to specific screening procedures. This document will prompt primary oncology providers to implement necessary screenings and diagnostic tests for these patients. The study utilizes a cross-sectional design to address organizational barriers in timely screening.

Why it matters

Potential benefit: If successful, this study could lead to earlier detection and management of sensory deficits in childhood cancer survivors, improving their quality of life.

How similar studies have gone: Other studies have shown success in implementing screening protocols for childhood cancer survivors, indicating that this approach has potential.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with a diagnosis of pediatric cancer (diagnosis at \<18 years of age)
* Treatment including chemotherapy and/or radiation therapy
* Completion of all cancer therapy for at least 6 months and less than 2 years
* Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine
* Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group)
* English speaking

Exclusion Criteria:

* Undergoing active cancer treatment
* Patient under the care of the Late Effects Program at St. Louis Children's Hospital
* Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening.
* Parents and/or patient illiteracy
* No contact with treatment team in the past two years
* In foster care or without a legal guardian

Where it's running

  • St. Louis Children's Hospital - Washington University School of Medicine
    St Louis, Missouri, United States
    Recruiting

Study contacts

  • Principal investigator: Robert J Hayashi, M.D. — Washington University School of Medicine
  • Study coordinator: Robert J Hayashi, M.D.
  • Email: hayashi_r@wustl.edu
  • Phone: 314-454-6018

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.